$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 41,895 | 0 | 1,186,602 | 1.1 M to 1.2 M (+3.66 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 30.39 | 37,659 | 1,144,457 | 1,144,707 | 1.2 M to 1.1 M (-3.19 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 29.78 | 7,939 | 236,423 | 1,182,366 | 1.2 M to 1.2 M (-0.67 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 16,000 | 43,840 | 34,000 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 44,000 | 120,560 | 0 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 41,895 | 0 | 83,792 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 16,000 | 43,840 | 1,246,602 | 1.2 M to 1.2 M (+1.30 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 44,000 | 120,560 | 1,230,602 | 1.2 M to 1.2 M (+3.71 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 41,895 | 0 | 1,186,602 | 1.1 M to 1.2 M (+3.66 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 19,638 | 0 | 19,829 | 191 to 19.8 K (+10,281.68 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 30.39 | 37,659 | 1,144,457 | 1,144,707 | 1.2 M to 1.1 M (-3.19 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 30.46 | 17,513 | 533,446 | 191 | 17.7 K to 191 (-98.92 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 29.78 | 7,939 | 236,423 | 1,182,366 | 1.2 M to 1.2 M (-0.67 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 29.80 | 3,945 | 117,561 | 17,704 | 21.6 K to 17.7 K (-18.22 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 19,638 | 0 | 38,438 | 18.8 K to 38.4 K (+104.46 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 30.40 | 17,591 | 534,766 | 18,800 | 36.4 K to 18.8 K (-48.34 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 29.80 | 3,867 | 115,237 | 36,391 | 40.3 K to 36.4 K (-9.61 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 19,638 | 0 | 19,829 | 191 to 19.8 K (+10,281.68 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 30.46 | 17,513 | 533,446 | 191 | 17.7 K to 191 (-98.92 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 29.80 | 3,945 | 117,561 | 17,704 | 21.6 K to 17.7 K (-18.22 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 19,638 | 0 | 39,277 | |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 19,638 | 0 | 38,438 | 18.8 K to 38.4 K (+104.46 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 30.40 | 17,591 | 534,766 | 18,800 | 36.4 K to 18.8 K (-48.34 %) |
| Jan 08 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 29.80 | 3,867 | 115,237 | 36,391 | 40.3 K to 36.4 K (-9.61 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 34.30 | 25 | 858 | 191 | 216 to 191 (-11.57 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 33.23 | 1,200 | 39,876 | 216 | 1.4 K to 216 (-84.75 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 32.43 | 4,959 | 160,820 | 1,416 | 6.4 K to 1.4 K (-77.79 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 31.83 | 1,623 | 51,660 | 6,375 | 8 K to 6.4 K (-20.29 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 40,258 | 24.1 K to 40.3 K (+67.06 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 24,098 | 18.8 K to 24.1 K (+28.18 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,000 | 0 | 18,800 | 19.8 K to 18.8 K (-5.05 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 34.30 | 25 | 858 | 19,800 | 19.8 K to 19.8 K (-0.13 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 33.28 | 1,000 | 33,280 | 19,825 | 20.8 K to 19.8 K (-4.80 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 32.46 | 4,982 | 161,716 | 20,825 | 25.8 K to 20.8 K (-19.30 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.84 | 1,800 | 57,312 | 25,807 | 27.6 K to 25.8 K (-6.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 27,607 | 19.8 K to 27.6 K (+39.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 34,341 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 6,000 | 16,440 | 44,000 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,190,305 | 1.2 M to 1.2 M (+2.97 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,155,965 | 1.1 M to 1.2 M (+0.98 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 34.30 | 56 | 1,921 | 1,144,707 | 1.1 M to 1.1 M (0.00 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 33.25 | 3,000 | 99,750 | 1,144,763 | 1.1 M to 1.1 M (-0.26 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 32.43 | 10,722 | 347,714 | 1,147,763 | 1.2 M to 1.1 M (-0.93 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 31.85 | 3,700 | 117,845 | 1,158,485 | 1.2 M to 1.2 M (-0.32 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 6,000 | 16,440 | 1,162,185 | 1.2 M to 1.2 M (+0.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 34.31 | 170 | 5,833 | 6,832 | 6.7 K to 6.8 K (+2.55 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 34.30 | 25 | 858 | 191 | 216 to 191 (-11.57 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 33.23 | 1,200 | 39,876 | 216 | 1.4 K to 216 (-84.75 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 32.43 | 4,959 | 160,820 | 1,416 | 6.4 K to 1.4 K (-77.79 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 31.83 | 1,623 | 51,660 | 6,375 | 8 K to 6.4 K (-20.29 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 16,160 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 40,258 | 24.1 K to 40.3 K (+67.06 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 24,098 | 18.8 K to 24.1 K (+28.18 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,000 | 0 | 18,800 | 19.8 K to 18.8 K (-5.05 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 34.30 | 25 | 858 | 19,800 | 19.8 K to 19.8 K (-0.13 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 33.28 | 1,000 | 33,280 | 19,825 | 20.8 K to 19.8 K (-4.80 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 32.46 | 4,982 | 161,716 | 20,825 | 25.8 K to 20.8 K (-19.30 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 31.84 | 1,800 | 57,312 | 25,807 | 27.6 K to 25.8 K (-6.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 27,607 | 19.8 K to 27.6 K (+39.43 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 34,341 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 0 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 2.74 | 6,000 | 16,440 | 44,000 | |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,190,305 | 1.2 M to 1.2 M (+2.97 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,155,965 | 1.1 M to 1.2 M (+0.98 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 34.30 | 56 | 1,921 | 1,144,707 | 1.1 M to 1.1 M (0.00 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 33.25 | 3,000 | 99,750 | 1,144,763 | 1.1 M to 1.1 M (-0.26 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 32.43 | 10,722 | 347,714 | 1,147,763 | 1.2 M to 1.1 M (-0.93 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 31.85 | 3,700 | 117,845 | 1,158,485 | 1.2 M to 1.2 M (-0.32 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 2.74 | 6,000 | 16,440 | 1,162,185 | 1.2 M to 1.2 M (+0.52 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 34.31 | 170 | 5,833 | 6,832 | 6.7 K to 6.8 K (+2.55 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 34.31 | 422 | 14,479 | 44,727 | 44.3 K to 44.7 K (+0.95 %) |
| Jan 03 2020 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 34.31 | 422 | 14,479 | 343,586 | 343.2 K to 343.6 K (+0.12 %) |
| Dec 26 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 2.74 | 9,600 | 26,304 | 0 | |
| Dec 26 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 25.50 | 5,432 | 138,516 | 19,800 | 25.2 K to 19.8 K (-21.53 %) |
| Dec 26 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 25.50 | 9,600 | 244,800 | 25,232 | 34.8 K to 25.2 K (-27.56 %) |
| Dec 26 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 2.74 | 9,600 | 26,304 | 34,832 | 25.2 K to 34.8 K (+38.05 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 26,896 | |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 13,448 | 0 | 26,896 | |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 8.25 | 6,774 | 55,886 | 6,674 | 13.4 K to 6.7 K (-50.37 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Sell | S | 8.25 | 6,774 | 55,886 | 6,674 | 13.4 K to 6.7 K (-50.37 %) |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 13,448 | 0 to 13.4 K |
| Oct 17 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Buy | M | 0.00 | 13,448 | 0 | 13,448 | 0 to 13.4 K |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 7.47 | 1,941 | 14,499 | 44,305 | 42.4 K to 44.3 K (+4.58 %) |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 7.47 | 1,840 | 13,745 | 70,938 | 69.1 K to 70.9 K (+2.66 %) |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 7.47 | 780 | 5,827 | 6,662 | 5.9 K to 6.7 K (+13.26 %) |
| Oct 02 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 7.47 | 1,941 | 14,499 | 343,164 | 341.2 K to 343.2 K (+0.57 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 11.00 | 6,240 | 68,640 | 4,673,270 | 4.7 M to 4.7 M (+0.13 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 10.58 | 320,095 | 3,386,605 | 4,667,030 | 4.3 M to 4.7 M (+7.36 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 9.59 | 155,116 | 1,487,562 | 4,346,935 | 4.2 M to 4.3 M (+3.70 %) |
| Sep 11 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 8.98 | 3,549 | 31,870 | 4,191,819 | 4.2 M to 4.2 M (+0.08 %) |
| Sep 04 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 8.52 | 125,000 | 1,065,213 | 4,188,270 | 4.1 M to 4.2 M (+3.08 %) |
| Jul 02 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 12.98 | 449 | 5,828 | 5,882 | 5.4 K to 5.9 K (+8.26 %) |
| Jul 02 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 12.98 | 1,059 | 13,746 | 69,098 | 68 K to 69.1 K (+1.56 %) |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 13.05 | 20,000 | 261,000 | 20,000 | |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 14,005 | 0 | 14,005 | |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 13.05 | 20,000 | 261,000 | 20,000 | |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 13.05 | 20,000 | 261,000 | 20,000 | |
| Jun 26 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 0.00 | 14,005 | 0 | 14,005 | |
| Jun 19 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Gift | G | 0.00 | 400,000 | 0 | 340,106 | 740.1 K to 340.1 K (-54.05 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 12.00 | 58,705 | 704,460 | 170,000 | 111.3 K to 170 K (+52.75 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 11.70 | 95,069 | 1,112,307 | 111,295 | 16.2 K to 111.3 K (+585.91 %) |
| Jun 14 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 10.91 | 16,226 | 177,026 | 16,226 | 0 to 16.2 K |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 12.45 | 20,000 | 249,000 | 0 | |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 20,000 | 0 | 98,742 | 78.7 K to 98.7 K (+25.40 %) |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 20,000 | 0 | 21,671 | 41.7 K to 21.7 K (-48.00 %) |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 12.45 | 20,000 | 249,000 | 41,671 | 21.7 K to 41.7 K (+92.29 %) |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 12.45 | 20,000 | 249,000 | 0 | |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 20,000 | 0 | 98,742 | 78.7 K to 98.7 K (+25.40 %) |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 20,000 | 0 | 21,671 | 41.7 K to 21.7 K (-48.00 %) |
| May 31 2019 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 12.45 | 20,000 | 249,000 | 41,671 | 21.7 K to 41.7 K (+92.29 %) |
| May 15 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 12.56 | 100,000 | 1,256,350 | 4,053,270 | 4 M to 4.1 M (+2.53 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 12.18 | 1,190 | 14,494 | 750,106 | 748.9 K to 750.1 K (+0.16 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 12.18 | 478 | 5,822 | 5,433 | 5 K to 5.4 K (+9.65 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 12.18 | 1,190 | 14,494 | 41,247 | 40.1 K to 41.2 K (+2.97 %) |
| Apr 02 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 12.18 | 1,128 | 13,739 | 68,039 | 66.9 K to 68 K (+1.69 %) |
| Mar 01 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 2.74 | 400 | 1,096 | 9,600 | |
| Mar 01 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 2.74 | 10,000 | 27,400 | 0 | |
| Mar 01 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 15.00 | 1,000 | 15,000 | 25,232 | 26.2 K to 25.2 K (-3.81 %) |
| Mar 01 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 2.74 | 400 | 1,096 | 26,232 | 25.8 K to 26.2 K (+1.55 %) |
| Mar 01 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 2.74 | 10,000 | 27,400 | 25,832 | 15.8 K to 25.8 K (+63.16 %) |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 68,735 | 0 | 68,735 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 12.73 | 94,443 | 1,202,259 | 94,443 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 62,843 | 0 | 62,843 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 12.73 | 86,348 | 1,099,210 | 86,348 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 125,687 | 0 | 125,687 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 12.73 | 172,697 | 2,198,433 | 172,697 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 125,687 | 0 | 125,687 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 12.43 | 6,604 | 82,088 | 1,138,707 | 1.1 M to 1.1 M (-0.58 %) |